Traws Pharma, Inc. Common Stock (TRAW) is a publicly traded Healthcare sector company. As of July 11, 2026, TRAW trades at $0.74 with a market cap of $10.28M and a P/E ratio of 0.93. TRAW moved +6.65% today. Year to date, TRAW is -32.74%; over the trailing twelve months it is -51.59%. Its 52-week range spans $0.64 to $19.44. Analyst consensus is neutral with an average price target of $1.00. Rallies surfaces TRAW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Traws Pharma, Inc. Common Stock (TRAW) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TRAW moved +6.65% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $0.74 |
| Market Cap | $10.28M |
| P/E Ratio | 0.93 |
| EPS | $0.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.44 |
| 52-Week Low | $0.64 |
| Volume | 119.83K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.79M |
| Net Income | $9.17M |
| Gross Margin | 0.00% |
2 analysts cover TRAW: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.00.